Nike (NKE) exceeded expectations in its Q2 results, delivering both top and bottom-line growth. Despite this, a cautious outlook for the holiday quarter and ong
Nike Inc (NYSE:NKE, XETRA:NKE) will report its fiscal second quarter results on December 18, with UBS analysts expecting a relatively muted reaction from Wall Street despite signs of uneven momentum across the athletic footwear and apparel brand's key markets. The firm repeated its ‘Neutral' rating and a $71 price target, writing that they “don't expect Nike's print to change Street estimates or the stock's price-to-earnings ratio (P/E) much.
Vancouver, British Columbia--(Newsfile Corp. - December 4, 2025) - Metalsource Mining, Inc. (CSE: MSM) (FSE: E9Z) (OTCQB: SFRIF) ("Metalsource" or the "Company"), is pleased to announce that its common shares have been made eligible for electronic clearing and settlement through the Depository Trust Company (DTC) in the United States. DTC eligibility streamlines the process of trading the Company's shares, allowing for faster settlement, simplified electronic transfers, and broader access to U.S brokerage firms & investors.
Montreal, Quebec--(Newsfile Corp. - December 4, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a biotechnology company advancing a proprietary intracellular delivery platform that enables more potent, safer, and more effective antibody-based and radiotherapeutic treatments, is pleased to announce the formation of its inaugural Scientific Advisory Board ("SAB"), composed of Rob Leanna, Danny Chui, and Brendan Hussey. Defence's Accum®-Antibody drug conjugate ("ADC") program has reached laboratory validations, demonstrating a significant increase in intracellular accumulation and improved efficacy for Accum®-enhanced ADCs.
Montreal, Quebec--(Newsfile Corp. - November 21, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a leading biotechnology company pioneering next-generation antibody-drug conjugate ("ADC"), announces that the holders of the Corporation's 8% convertible debentures issued on November 16, 2024 (the "Debentures") have converted all of the principal amount and the accrued interests thereof into an aggregate number of 2,607,600 common shares of the Company (each, a "Share") upon maturity of Debentures on November 16, 2025. In accordance with the terms of the Debentures, the principal amount of $1,476,000 was converted into 2,460,000 Shares at the conversion price of $0.60 per Share and an aggregate amount of $118,080 of accrued interests was converted into 147,600 Shares at $0.80 per Share totalling 2,607,600 Shares for an aggregate amount of $1,594,080.
Amer Sports (AS) shares are climbing after the company reported impressive Q3 results. The Finland-based athletic company exceeded expectations with a 30% year-
Paramount Skydance (PSKY), Comcast (CMCSA), and Netflix (NFLX) are gearing up to bid for Warner Bros. Discovery (WBD) ahead of the November 20 deadline. This mo
Walt Disney (DIS) slightly exceeded Q4 EPS expectations but fell short on revenue, which declined by 0.5% year-over-year to $22.46 billion. This marks Disney's
Pavilion to Demonstrate AI and Digital Twins Use Cases Aligned to Topical Panels and Sessions on National Defense Strategy and Naval Shipbuilding Advancements Arlington, Virginia--(Newsfile Corp. - November 13, 2025) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) ("edgeTI", "Company", "Edge Technologies") a leader in real-time digital operations and decision intelligence solutions, is back this year with the AI-Powered Digital Twin Pavilion with the Company's AI technology partners Sabel Systems and Austal Ltd. at the Defense TechConnect Innovation Summit and Expo (DTC), 2025 being held November 19th through the 21st at the Gaylord National Hotel & Convention Center, National Harbor, MD.
On Holding (ONON) saw a significant 19% increase in its stock after a strong Q3 earnings report and an upward revision of its guidance. The Swiss athletic footw